U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia

MedGen UID:
79004
•Concept ID:
C0279549
•
Neoplastic Process
Synonyms: Myelodysplastic-myeloproliferative neoplasm with neutrophilia; Myelodysplastic/myeloproliferative neoplasm with neutrophilia; Ph Negative Chronic Myelogenous Leukemia; Ph' Chromosome Negative Chronic Granulocytic Leukemia; Ph' Chromosome Negative Chronic Myelocytic Leukemia; Ph' Chromosome Negative Chronic Myeloid Leukemia; Ph' Negative Chronic Granulocytic Leukemia; Ph- Chronic Myelogenous Leukemia; Ph1 Chromosome Negative Chronic Myelocytic Leukemia; Ph1 Chromosome Negative Chronic Myelogenous Leukemia; Philadelphia Chromosome Negative BCR-ABL1 Positive Chronic Myelogenous Leukemia; Philadelphia Chromosome Negative Chronic Granulocytic Leukemia; Philadelphia Chromosome Negative Chronic Myelocytic Leukemia; Philadelphia Chromosome Negative Chronic Myelogenous Leukemia; Philadelphia Chromosome Negative Chronic Myeloid Leukemia; Philadelphia Chromosome Negative, BCR::ABL1 Positive Chronic Myelogenous Leukemia
SNOMED CT: Myelodysplastic-myeloproliferative neoplasm with neutrophilia (277589003); Myelodysplastic/myeloproliferative neoplasm with neutrophilia (277589003)

Definition

A chronic myelogenous leukemia which does not have the characteristic t(9;22)(q34;q11.2) translocation but it has either a variant translocation or a cryptic translocation that can not be detected by conventional cytogenetic analysis. In such cases the BCR-ABL1 fusion gene is always detected by RT-PCR, FISH, or Southern blot analysis. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVPhiladelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Professional guidelines

PubMed

Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow-up.
Romzova M, Smitalova D, Hynst J, Tom N, Loja T, Herudkova Z, Jurcek T, Stejskal L, Zackova D, Mayer J, Racil Z, Culen M
Br J Haematol 2021 Aug;194(3):604-612. Epub 2021 Jul 1 doi: 10.1111/bjh.17659. PMID: 34212373
Monocyte subsets and their phenotypes during treatment with BCR-ABL1 tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia.
Konuma T, Kohara C, Watanabe E, Mizukami M, Nagai E, Tanoue S, Isobe M, Jimbo K, Kato S, Ohno N, Takahashi S, Tojo A
Hematol Oncol 2018 Apr;36(2):451-456. Epub 2018 Feb 12 doi: 10.1002/hon.2497. PMID: 29431866
Chronic myeloid leukemia: cytogenetic methods and applications for diagnosis and treatment.
Morris CM
Methods Mol Biol 2011;730:33-61. doi: 10.1007/978-1-61779-074-4_4. PMID: 21431633

Recent clinical studies

Etiology

FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions.
May PC, Reid AG, Robinson ME, Khorashad JS, Milojkovic D, Claudiani S; Genomics England Research Consortium, Willis F, Apperley JF, Innes AJ
BMC Med Genomics 2023 Jul 26;16(1):172. doi: 10.1186/s12920-023-01607-7. PMID: 37496024Free PMC Article
De novo lymphoid blastic phase chronic myeloid leukemia: report and contemporary discussion.
Hameed M, Alnoamani M, Marei M, Tailor I, Alshehri H, Tashkandi SA, Alswayyed A, Alrajhi AM, Zaidi SZA, Motabi I, AlShehry N, Alfayez M
Hematology 2022 Dec;27(1):1259-1262. doi: 10.1080/16078454.2022.2150386. PMID: 36448578
Chronic Myeloid Leukemia: Beyond BCR-ABL1.
Zhou T, Medeiros LJ, Hu S
Curr Hematol Malig Rep 2018 Dec;13(6):435-445. doi: 10.1007/s11899-018-0474-6. PMID: 30370478
Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors.
Pietarinen PO, Eide CA, Ayuda-Durán P, Potdar S, Kuusanmäki H, Andersson EI, Mpindi JP, Pemovska T, Kontro M, Heckman CA, Kallioniemi O, Wennerberg K, Hjorth-Hansen H, Druker BJ, Enserink JM, Tyner JW, Mustjoki S, Porkka K
Oncotarget 2017 Apr 4;8(14):22606-22615. doi: 10.18632/oncotarget.15146. PMID: 28186983Free PMC Article
Chronic myeloid leukemia: cytogenetic methods and applications for diagnosis and treatment.
Morris CM
Methods Mol Biol 2011;730:33-61. doi: 10.1007/978-1-61779-074-4_4. PMID: 21431633

Diagnosis

FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions.
May PC, Reid AG, Robinson ME, Khorashad JS, Milojkovic D, Claudiani S; Genomics England Research Consortium, Willis F, Apperley JF, Innes AJ
BMC Med Genomics 2023 Jul 26;16(1):172. doi: 10.1186/s12920-023-01607-7. PMID: 37496024Free PMC Article
Distinguishing atypical chronic myeloid leukemia from other Philadelphia-negative chronic myeloproliferative neoplasms.
Sadigh S, Hasserjian RP, Hobbs G
Curr Opin Hematol 2020 Mar;27(2):122-127. doi: 10.1097/MOH.0000000000000565. PMID: 31904665
Chronic Myeloid Leukemia: Beyond BCR-ABL1.
Zhou T, Medeiros LJ, Hu S
Curr Hematol Malig Rep 2018 Dec;13(6):435-445. doi: 10.1007/s11899-018-0474-6. PMID: 30370478
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.
Cortes JE, Gambacorti-Passerini C, Deininger MW, Mauro MJ, Chuah C, Kim DW, Dyagil I, Glushko N, Milojkovic D, le Coutre P, Garcia-Gutierrez V, Reilly L, Jeynes-Ellis A, Leip E, Bardy-Bouxin N, Hochhaus A, Brümmendorf TH
J Clin Oncol 2018 Jan 20;36(3):231-237. Epub 2017 Nov 1 doi: 10.1200/JCO.2017.74.7162. PMID: 29091516Free PMC Article
Molecular pathogenesis of Philadelphia-positive chronic myeloid leukemia - is it all BCR-ABL?
Rumpold H, Webersinke G
Curr Cancer Drug Targets 2011 Jan;11(1):3-19. doi: 10.2174/156800911793743619. PMID: 21062244

Therapy

Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.
Yung Y, Lee E, Chu HT, Yip PK, Gill H
Int J Mol Sci 2021 Jan 11;22(2) doi: 10.3390/ijms22020659. PMID: 33440869Free PMC Article
Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study.
Hochhaus A, Gambacorti-Passerini C, Abboud C, Gjertsen BT, Brümmendorf TH, Smith BD, Ernst T, Giraldo-Castellano P, Olsson-Strömberg U, Saussele S, Bardy-Bouxin N, Viqueira A, Leip E, Russell-Smith TA, Leone J, Rosti G, Watts J, Giles FJ; BYOND Study Investigators
Leukemia 2020 Aug;34(8):2125-2137. Epub 2020 Jun 22 doi: 10.1038/s41375-020-0915-9. PMID: 32572189Free PMC Article
Philadelphia+ Chronic Myeloid Leukemia with CALR Mutation: A Case Report and Literature Review.
Yoon SY, Jeong SY, Kim C, Lee MY, Kim J, Kim KH, Lee N, Won JH
Cancer Res Treat 2020 Jul;52(3):987-991. Epub 2020 Jan 15 doi: 10.4143/crt.2019.703. PMID: 32019282Free PMC Article
Monocyte subsets and their phenotypes during treatment with BCR-ABL1 tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia.
Konuma T, Kohara C, Watanabe E, Mizukami M, Nagai E, Tanoue S, Isobe M, Jimbo K, Kato S, Ohno N, Takahashi S, Tojo A
Hematol Oncol 2018 Apr;36(2):451-456. Epub 2018 Feb 12 doi: 10.1002/hon.2497. PMID: 29431866
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.
Cortes JE, Gambacorti-Passerini C, Deininger MW, Mauro MJ, Chuah C, Kim DW, Dyagil I, Glushko N, Milojkovic D, le Coutre P, Garcia-Gutierrez V, Reilly L, Jeynes-Ellis A, Leip E, Bardy-Bouxin N, Hochhaus A, Brümmendorf TH
J Clin Oncol 2018 Jan 20;36(3):231-237. Epub 2017 Nov 1 doi: 10.1200/JCO.2017.74.7162. PMID: 29091516Free PMC Article

Prognosis

A Case Report of Successful Kidney Transplantation in a Patient With Chronic Myelogenous Leukemia (CML) Who Has Been in Remission for 15 Years on Imatinib.
Tokumoto T, Setoguchi K, Osaka A, Ikezoe E, Tsujioka H, Hasegawa K, Inoue M, Nirazuka A, Iwahata T, Inoue Y, Saito K
Transplant Proc 2023 May;55(4):1074-1077. Epub 2023 May 3 doi: 10.1016/j.transproceed.2023.03.058. PMID: 37147192
Philadelphia+ Chronic Myeloid Leukemia with CALR Mutation: A Case Report and Literature Review.
Yoon SY, Jeong SY, Kim C, Lee MY, Kim J, Kim KH, Lee N, Won JH
Cancer Res Treat 2020 Jul;52(3):987-991. Epub 2020 Jan 15 doi: 10.4143/crt.2019.703. PMID: 32019282Free PMC Article
Distinguishing atypical chronic myeloid leukemia from other Philadelphia-negative chronic myeloproliferative neoplasms.
Sadigh S, Hasserjian RP, Hobbs G
Curr Opin Hematol 2020 Mar;27(2):122-127. doi: 10.1097/MOH.0000000000000565. PMID: 31904665
Chronic Myeloid Leukemia: Beyond BCR-ABL1.
Zhou T, Medeiros LJ, Hu S
Curr Hematol Malig Rep 2018 Dec;13(6):435-445. doi: 10.1007/s11899-018-0474-6. PMID: 30370478
Chronic myeloid leukemia: cytogenetic methods and applications for diagnosis and treatment.
Morris CM
Methods Mol Biol 2011;730:33-61. doi: 10.1007/978-1-61779-074-4_4. PMID: 21431633

Clinical prediction guides

Occurrence of L1M Elements in Chromosomal Rearrangements Associated to Chronic Myeloid Leukemia (CML): Insights from Patient-Specific Breakpoints Characterization.
L'Abbate A, Moretti V, Pungolino E, Micheloni G, Valli R, Frattini A, Barcella M, Acquati F, Reinbold RA, Costantino L, Ferrara F, Trojani A, Ventura M, Porta G, Cairoli R
Genes (Basel) 2023 Jun 27;14(7) doi: 10.3390/genes14071351. PMID: 37510256Free PMC Article
Saudi Arabian CML patient with a novel four-way translocation at t(9;22;5;2)(q34;q11.2;p13;q44).
Dridi W, Kanfar S, Sleiman PMA, Liu Y, Hakonarson H, Rammah H, Matrouk A
Mol Genet Genomic Med 2022 Jun;10(6):e1865. Epub 2022 May 11 doi: 10.1002/mgg3.1865. PMID: 35543309Free PMC Article
Philadelphia+ Chronic Myeloid Leukemia with CALR Mutation: A Case Report and Literature Review.
Yoon SY, Jeong SY, Kim C, Lee MY, Kim J, Kim KH, Lee N, Won JH
Cancer Res Treat 2020 Jul;52(3):987-991. Epub 2020 Jan 15 doi: 10.4143/crt.2019.703. PMID: 32019282Free PMC Article
Expression of dominant-negative Ikaros isoforms and associated genetic alterations in Chinese adult patients with leukemia.
Liu P, Lin Z, Qian S, Qiao C, Qiu H, Wu Y, Li J, Ge Z
Ann Hematol 2012 Jul;91(7):1039-49. Epub 2012 Feb 11 doi: 10.1007/s00277-012-1415-4. PMID: 22323189
Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapy.
Yanada M, Sugiura I, Takeuchi J, Akiyama H, Maruta A, Ueda Y, Usui N, Yagasaki F, Yujiri T, Takeuchi M, Nishii K, Kimura Y, Miyawaki S, Narimatsu H, Miyazaki Y, Ohtake S, Jinnai I, Matsuo K, Naoe T, Ohno R; Japan Adult Leukemia Study Group
Br J Haematol 2008 Nov;143(4):503-10. doi: 10.1111/j.1365-2141.2008.07377.x. PMID: 18986386

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...